New Alzheimer’s Drug May Stop Disease Progression
Researchers have identified a novel monoclonal antibody therapy that demonstrates a significant reduction in amyloid-beta plaque accumulation, the hallmark of Alzheimer’s disease. Clinical trials indicate this therapeutic approach may slow ... Read More